CHARLESTON, S.C., Nov. 8, 2011 (GLOBE NEWSWIRE) -- Revolutions Medical Corporation ("Revolutions Medical" or the "Company") is exhibiting its auto-retractable vacuum safety syringe technology at the Parenteral Drug Association (PDA) conference in Basel, Switzerland, from November 7-11, 2011. There are 83 companies exhibiting with over 600 participants attending various presentations, case studies, and poster sessions, making this the biggest pre-filled syringe and injective device conference of its kind in the world. Recently, there have been extensive changes to regulations and legislation, requiring new developments and improvements in pre-filled technology and materials including design, integration, validation and selection plus patient safety issues and end-user needs. Revolutions Medical believes that its proprietary auto-retractable vacuum technology can be helpful in providing a safe injection device to the numerous pre-filled drugs that can be delivered to the market.
Ron Wheet, Chief Executive Officer and Chairman of Revolutions Medical, stated, "The pre-filled syringe market has tremendous growth opportunities. This is the first pre-filled device conference we have attended and feel that this opens up new and significant opportunities for our proprietary products. I am very pleased with the attention our technology is receiving and look forward to the rest of the week."
For more information, go to http://europe.pda.org
About Revolutions Medical Corporation
Revolutions Medical is a safety medical device and software application company. Its products include the RevVac™ Safety Syringe (FDA cleared), safety blood drawing device, the RevColor™, RevDisplay™ and Rev3D™ software tools that are compatible with standard MRIs and standard Picture Archiving Computer Systems (PACS).
For additional information, please visit Revolutions Medical corporate website:
http://www.revolutionsmedical.com
To be added to the Revolutions Medical investor email list, please email:
investment@revolutionsmedical.com with RMCP in the subject line.
FORWARD-LOOKING STATEMENTS
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.